What insulin types and dosing regimens are recommended for adults with type 1 diabetes or insulin‑requiring type 2 diabetes?

Insulin Types and Dosing for Adults with Diabetes

For type 1 diabetes, initiate multiple daily injections with rapid-acting insulin analogues (aspart, lispro, or glulisine) before meals combined with long-acting basal insulin analogues (glargine or detemir); for type 2 diabetes requiring insulin, start with once-daily basal insulin and intensify stepwise to basal-bolus or premixed regimens only if glycemic targets are not met.

Type 1 Diabetes: Insulin Regimen

Multiple daily injections (MDI) is the standard approach 1. This consists of:

Basal Insulin Component

• Long-acting insulin analogues (glargine or detemir) are preferred over NPH insulin 2, 3
• These provide superior duration of action, reduced peak effect, lower intraindividual variability, and decreased nocturnal hypoglycemia risk 1
• Dosed once daily (glargine) or once to twice daily (detemir)
• Consider long-acting analogues specifically for patients experiencing frequent severe hypoglycemia with human insulin 2

Prandial Insulin Component

• Rapid-acting analogues (aspart, lispro, glulisine) are preferred over regular human insulin 3, 1
• Administered 0-15 minutes before each meal 3
• Faster-acting insulin aspart offers even better postprandial glucose coverage 1

Dosing Strategy

• Titrate basal insulin using fasting plasma glucose values
• Titrate prandial insulin using both fasting and postprandial glucose measurements 3
• Patients must learn carbohydrate counting, premeal glucose adjustments, and activity-based dosing 1

Glycemic Target

• HbA1c < 7% (53 mmol/mol) for most nonpregnant adults 1
• For children with type 1 diabetes: HbA1c < 7.5% (58 mmol/mol) 3

Alternative Regimen

• Premixed insulin 2-3 times daily can be used but is less flexible 3
• Continuous subcutaneous insulin infusion (insulin pump) should be considered for patients not meeting targets, experiencing frequent/severe hypoglycemia, or with pronounced dawn phenomenon 1

Type 2 Diabetes: Stepwise Insulin Initiation

When to Start Insulin

Insulin is indicated when 3:

• HbA1c ≥ 7.5% (58 mmol/mol) despite optimal oral agents
• HbA1c ≥ 10% (86 mmol/mol) - insulin is essential
• Acute illness, surgery, or pregnancy
• Severe hyperglycemia with symptoms (glucose ≥ 300 mg/dL)

Step 1: Basal Insulin Initiation

Start with once-daily long-acting basal insulin 3, 4, 5. This is the preferred first-line insulin approach:

• Long-acting analogues (glargine, detemir) preferred over NPH due to reduced hypoglycemia risk 4
• Alternative: once-daily premixed insulin 3
• Continue metformin with insulin - this combination reduces weight gain, lowers insulin dose requirements, and decreases hypoglycemia compared to insulin alone 3
• Do not abruptly discontinue oral medications when starting insulin (risk of rebound hyperglycemia) 3

Step 2: Intensification if Targets Not Met

If basal insulin alone doesn't achieve goals 6, 3:

Basal-bolus regimen:

• Add rapid-acting insulin at mealtimes
• Provides HbA1c reduction of 3.4 mmol/mol (0.31%) beyond basal alone 6
• Trade-off: approximately 1 kg additional weight gain and borderline increased hypoglycemia risk 6

Biphasic (premixed) insulin:

• Twice-daily dosing
• HbA1c reduction of 2.7 mmol/mol (0.24%) beyond basal alone 6
• Similar weight gain and hypoglycemia profile 6

Prandial-only insulin:

• HbA1c reduction of 4.1 mmol/mol (0.38%) beyond basal alone 6
• Less commonly used as initial intensification

Alternative to Intensification

If insulin intensification is unsuitable, consider adding 2:

• DPP-4 inhibitor
• SGLT-2 inhibitor
• Thiazolidinedone (TZD)
• GLP-1 receptor agonist 3

Practical Dosing Conversions

When transitioning between basal insulins 7:

NPH to glargine or detemir:

• Once-daily NPH: convert unit-to-unit (1:1)
• Twice-daily NPH: reduce total basal dose by 20% when converting

Glargine to detemir:

• Increase dose when transitioning from glargine to detemir (not 1:1 interchangeable) 7

Titration Frequency

• Titrate insulin every 2-3 days until blood glucose targets are reached 4
• Use fasting glucose for basal insulin adjustments
• Use postprandial glucose for prandial insulin adjustments 3

Critical Safety Considerations

Injection Technique

• Use 4-mm pen needles or 6-mm syringe needles - shortest needles are safest, most effective, less painful, and should be first-line 3
• Avoid intramuscular injections, especially with long-acting insulins (risk of severe hypoglycemia) 3
• Rotate injection sites to prevent lipohypertrophy, which distorts insulin absorption 3

Monitoring

• Blood glucose monitoring is integral and non-negotiable 3
• Continuous glucose monitoring may improve control regardless of regimen 1, 4

Common Pitfalls

The evidence shows complex insulin regimens (basal-bolus, biphasic) provide only modest glycemic benefits (0.24-0.38% HbA1c reduction) over basal insulin alone, but consistently cause more weight gain and increased hypoglycemia 6. Therefore, avoid premature intensification - ensure basal insulin is optimally titrated first before adding complexity.

Human insulin remains a strong recommendation in resource-limited settings 2, but where available, analogues offer meaningful clinical advantages in hypoglycemia reduction without compromising efficacy 3, 1.

budget:budget_used 6797 5862 935 0.0